USD 0.01
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 142.64 Thousand AUD | -54.73% |
2022 | 315.12 Thousand AUD | 80.55% |
2021 | 174.53 Thousand AUD | 0.0% |
2020 | - AUD | -100.0% |
2019 | 97.97 Thousand AUD | 127.59% |
2018 | -355.13 Thousand AUD | -204.28% |
2017 | 340.55 Thousand AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 142.64 Thousand AUD | -54.73% |
2023 Q3 | - AUD | 0.0% |
2023 Q4 | 142.64 Thousand AUD | 0.0% |
2023 Q1 | - AUD | -100.0% |
2023 Q2 | - AUD | 0.0% |
2022 Q2 | 1.00 AUD | 0.0% |
2022 Q4 | 315.12 Thousand AUD | 0.0% |
2022 FY | 315.12 Thousand AUD | 80.55% |
2022 Q1 | 1.00 AUD | -100.0% |
2022 Q3 | - AUD | -100.0% |
2021 Q1 | - AUD | 0.0% |
2021 FY | 174.53 Thousand AUD | 0.0% |
2021 Q4 | 143.18 Thousand AUD | 14318800.0% |
2021 Q3 | 1.00 AUD | 0.0% |
2021 Q2 | - AUD | 0.0% |
2020 FY | - AUD | -100.0% |
2020 Q1 | 1.00 AUD | -100.0% |
2020 Q2 | 1.00 AUD | 0.0% |
2020 Q4 | - AUD | 0.0% |
2020 Q3 | - AUD | -100.0% |
2019 Q1 | - AUD | 100.0% |
2019 Q3 | - AUD | 0.0% |
2019 Q4 | 97.97 Thousand AUD | 0.0% |
2019 FY | 97.97 Thousand AUD | 127.59% |
2019 Q2 | - AUD | 0.0% |
2018 Q4 | -355.13 Thousand AUD | 0.0% |
2018 Q2 | - AUD | 0.0% |
2018 Q1 | - AUD | -100.0% |
2018 FY | -355.13 Thousand AUD | -204.28% |
2018 Q3 | - AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2017 Q1 | - AUD | 0.0% |
2017 FY | 340.55 Thousand AUD | 0.0% |
2017 Q4 | 340.55 Thousand AUD | 34055400.0% |
2017 Q3 | 1.00 AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Bio Medica Corporation | 379 Thousand USD | 62.362% |
Arrayit Corporation | 464.19 Thousand USD | 69.269% |
Atlantic International Corp. | - USD | -Infinity% |
Biocept, Inc. | 757 Thousand USD | 81.156% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | -2385.00 USD | 6081.09% |
DermTech, Inc. | 1 Million USD | 85.792% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 95.676% |
HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 84.313% |
iMD Companies, Inc. | 38.31 Thousand USD | -272.296% |
IDenta Corp. | 442.28 Thousand USD | 67.747% |
Interpace Biosciences, Inc. | 1.22 Million USD | 88.374% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 163.13 Thousand USD | 12.558% |
Lumos Diagnostics Holdings Limited | 784 Thousand USD | 81.805% |
Many Bright Ideas Technologies Inc. | -375.00 USD | 38139.733% |
Medical Imaging Corp. | - USD | -Infinity% |
NovelStem International Corp. | - USD | -Infinity% |
Optigenex Inc. | 468.77 Thousand USD | 69.57% |
PharmChem, Inc. | 391.93 Thousand USD | 63.604% |
Proteome Sciences plc | 1.06 Million USD | 86.612% |
Response Genetics, Inc | 133 Thousand USD | -7.255% |
Rennova Health, Inc. | 242.64 Thousand USD | 41.211% |
RushNet, Inc. | - USD | -Infinity% |
ScreenPro Security Inc. | 73.89 Thousand USD | -93.038% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | 95.62 Thousand USD | -49.182% |
Todos Medical Ltd. | 1.02 Million USD | 86.028% |